查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555814

美國軟組織修復市場：規模、佔有率、趨勢分析（2024-2030）：MedSuite

Soft Tissue Repair Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 3 more
出版日期: | 出版商: iData Research Inc. | 英文 306 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，美國軟組織修復市場規模將超過30億美元。該市場預計將達到約 50億美元，預測期內年複合成長率為 7.2%。

美國的人口變化對軟組織修復市場產生正面影響。人口老化和肥胖率的增加日益增加疝氣和神經損傷等疾病的盛行率。2010年至2025年間，糖尿病患者人數預計將增加 64%。此外，美國65歲及以上人口的比例將從2016年的15.2%上升到2034年的23.4%，老年人口達到近8,000萬人。

美國軟組織修復市場共有三個主要參與者：Becton Dickinson（BD）、AbbVie 和 Integra LifeSciences。 Becton Dickinson（BD）以其廣泛的疝氣修復產品組合處於領先地位，特別是其Phasix（R）可吸收合成產品線。

艾伯維（AbbVie）在乳房重建和疝氣修復方面表現出色，使 AlloDerm（R）成為外科醫生的首選。 Integra LifeSciences 在神經硬腦膜修復領域脫穎而出，預計2023年引領市場。

本報告調查了美國軟組織修復市場，提供了市場概況以及細分趨勢、COVID-19 影響分析、市場驅動因素和抑制劑、競爭市場佔有率分析，以及進入市場的公司簡介。

目錄

執行摘要

調查方法

COVID-19 對美國軟組織修復市場的影響

  • 簡介
  • 區域概況
  • 依細分市場分析

疾病概論

  • 基本解剖學
  • 疾病的治療與診斷
  • 患者人口統計資料

產品評估

  • 簡介
  • 產品組合
  • 監理問題與召回
  • 臨床試驗

美國軟組織修復市場概況

  • 簡介
  • 市場概覽與趨勢分析
  • 促進因素和抑制因素
  • 競爭市佔率分析
  • 併購
  • 公司簡介
    • AbbVie
    • Artivion
    • Axogen
    • Becton Dickinson
    • Integra LifeSciences
    • Medtronic
    • MTF Biologics
    • Stryker
    • W.L. Gore
  • SWOT分析

程式數量

乳房重建市場

疝氣修補市場

硬腦膜修復市場

神經修復市場

心血管補片修復市場

Product Code: iDATA_USSTR24_MS

In 2023, the U.S. soft tissue repair market was valued at over $3 billion, and it is projected to grow at a CAGR of 7.2% over the forecast period, reaching approximately $5 billion. This comprehensive report on the U.S. soft tissue repair market covers breast reconstruction, hernia repair, dural repair, nerve repair, and cardiovascular patch repair.MARKET REPORT

COVERAGE:

Unit Sales, Average Selling Prices, Market Value & Growth Trends

Procedure Volumes

10-Year Scope (2020-2030)

Key Market Drivers & Limiters by Segment

Competitive Landscape and Market Shares by Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Insights

Company Profiles, Product Offerings, and SWOT Analyses for Major Players

U.S. SOFT TISSUE REPAIR MARKET TRENDS:

Shifting U.S. demographics are positively influencing the soft tissue repair market. Aging and increasing obesity rates raise the prevalence of conditions like hernias and nerve damage. The number of individuals with diabetes is expected to surge by 64% between 2010 and 2025. Additionally, the percentage of Americans aged 65 and over will rise from 15.2% in 2016 to 23.4% by 2034, bringing the elderly population to nearly 80 million.U.S.

SOFT TISSUE REPAIR MARKET COMPETITION:

There are three key players in the U.S. soft tissue repair market: Becton Dickinson (BD), AbbVie, and Integra LifeSciences.Becton Dickinson (BD) dominates with its expansive hernia repair portfolio, particularly the Phasix(R) resorbable synthetic product line.

AbbVie holds a strong second position, excelling in breast reconstruction and hernia repair, with AlloDerm(R) as a top choice among surgeons.

Integra LifeSciences stands out in nerve and dural repair, where it led the market in 2023.

MARKET SEGMENTATION OVERVIEW:

Breast Reconstruction Market - Comprising allografts, xenografts, and synthetic materials.

Hernia Repair Market - Encompassing allograft, xenograft, and synthetic devices used for inguinal, ventral, and hiatal hernia repairs.

Dural Repair Market - Divided into allograft, xenograft, and synthetic material categories.

Nerve Repair Market - Includes wraps, tubes, grafts, and cap products for nerve repair.

Cardiovascular Repair Market - Consists of both cardiac and vascular patches.

RESEARCH SCOPE SUMMARY:

Geographic Focus: United States

Base Year: 2023

Forecast Period: 2024-2030

Historical Data: 2020-2022

Quantitative Data: Market Size, Shares, Forecasts, Growth Rates, Units Sold, and Average Selling Prices

Qualitative Data: Market Trends, Limiters, Competitive Analysis, SWOT, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews

Data Sources: Primary industry interviews, physician and regulatory data, hospital and import/export data

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

U.S. Soft Tissue Repair Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedures Included

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE U.S. Soft Tissue repair Market

  • 2.1 Introduction
  • 2.2 Analysis By Market Segment
    • 2.2.1 Worst Case Scenario
    • 2.2.2 Base Case Scenario
    • 2.2.3 Best Case Scenario

Disease Overview

  • 3.1 Basic Anatomy
  • 3.2 Disease Treatment and Diagnostic
    • 3.2.1 Breast Cancer
    • 3.2.2 Cardiovascular Tissue Repair
    • 3.2.3 Dural Tears and Cerebrospinal Fluid Leakage Prevention
    • 3.2.4 Hernia
    • 3.2.5 Peripheral Vasculature Repair
    • 3.2.6 Traumas and Burns
  • 3.3 Patient Demographics
    • 3.3.1 Breast Cancer Statistics
    • 3.3.2 Cardiovascular Disease Statistics
    • 3.3.3 Hernia Repair Statistics
    • 3.3.4 Periodontitis Statistics
    • 3.3.5 Peripheral Vascular Disease (PVD) Statistics
    • 3.3.6 Traumatic and Sport-Related Injuries Statistics

Product Assessment

  • 4.1 Introduction
  • 4.2 Product Portfolios
    • 4.2.1 Breast Reconstruction Market
    • 4.2.2 Hernia Repair Market
    • 4.2.3 Dural Repair Market
    • 4.2.4 Nerve Repair Market
    • 4.2.5 Cardiovascular Repair
  • 4.3 Regulatory Issues and Recalls
    • 4.3.1 Hernia Repair
    • 4.3.2 Dural Repair
    • 4.3.3 Nerve Repair Market FDA Recalls
    • 4.3.4 Cardiovascular Repair
  • 4.4 Clinical Trials
    • 4.4.1 Breast Reconstruction
    • 4.4.2 Hernia Repair
    • 4.4.3 Dural Repair
    • 4.4.4 Nerve Repair
    • 4.4.5 Cardiovascular Repair

U.S. soft tissue repair Market Overview

  • 5.1 Introduction
  • 5.2 Market Overview & Trend Analysis
  • 5.3 Drivers and Limiters
    • 5.3.1 Market Drivers
    • 5.3.2 Market Limiters
  • 5.4 Competitive Market Share Analysis
  • 5.5 Mergers and Acquisitions
  • 5.6 Company Profiles
    • 5.6.1 AbbVie
    • 5.6.2 Artivion
    • 5.6.3 Axogen
    • 5.6.4 Becton Dickinson
    • 5.6.5 Integra LifeSciences
    • 5.6.6 Medtronic
    • 5.6.7 MTF Biologics
    • 5.6.8 Stryker
    • 5.6.9 W.L. Gore
  • 5.7 SWOT Analysis
    • 5.7.1 AbbVie
    • 5.7.2 Artivion
    • 5.7.3 Axogen
    • 5.7.4 Becton Dickinson
    • 5.7.5 Integra LifeSciences
    • 5.7.6 Medtronic
    • 5.7.7 MTF Biologics
    • 5.7.8 Stryker
    • 5.7.9 W.L. Gore

Procedure Numbers

  • 6.1 Introduction
  • 6.2 Procedures
    • 6.2.1 Breast Reconstruction Procedures
      • 6.2.1.1 Breast Reconstruction Procedures by Method
      • 6.2.1.1.1 Implant-Based Breast Reconstruction Procedures
      • 6.2.1.1.2 Autologous Breast Reconstruction Procedures
      • 6.2.1.2 Breast Reconstruction Procedures by Care Setting
    • 6.2.2 Hernia Repair Procedures
      • 6.2.2.1 Hernia Repair Procedures by Type
      • 6.2.2.2 Hernia Repair Procedures by Care Setting
      • 6.2.2.3 Hernia Repair Procedures by Robotic Assistance
    • 6.2.3 Dural Repair Procedures
    • 6.2.4 Cardiovascular Patch Repair Procedures
    • 6.2.5 Nerve Repair Procedures

Breast Reconstruction Market

  • 7.1 Introduction
  • 7.2 Market Overview
    • 7.2.1 Breast Reconstruction Market by Material Type
    • 7.2.2 Breast Reconstruction Market by Procedure Type
    • 7.2.3 Breast Reconstruction Market by Care Setting
  • 7.3 Market Analysis and Forecast
    • 7.3.1 Breast Reconstruction Market
    • 7.3.2 Allograft Breast Reconstruction Market
    • 7.3.3 Xenograft Breast Reconstruction Market
    • 7.3.4 Synthetic Breast Reconstruction Market
    • 7.3.5 Breast Reconstruction Market by Procedure Type
      • 7.3.5.1 Implant-Based Breast Reconstruction Market
      • 7.3.5.2 Autologous Breast Reconstruction Market
    • 7.3.6 Breast Reconstruction Market by Care Setting
      • 7.3.6.1 Hospital Breast Reconstruction Market
      • 7.3.6.2 Non-Hospital Breast Reconstruction Market
  • 7.4 Drivers and Limiters
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 Competitive Market Share Analysis

Hernia Repair Market

  • 8.1 Introduction
  • 8.2 Market Overview
    • 8.2.1 Hernia Repair Market by Segment
    • 8.2.2 Hernia Repair Market by Material Type
  • 8.3 Market Analysis and Forecast
    • 8.3.1 Hernia Repair Market
    • 8.3.2 Ventral Hernia Repair Market
      • 8.3.2.1 Allograft Ventral Hernia Repair Market
      • 8.3.2.2 Xenograft Ventral Hernia Repair Market
      • 8.3.2.2.1 Reinforced Xenograft Ventral Hernia Repair Market
      • 8.3.2.2.2 Non-Reinforced Xenograft Ventral Hernia Repair Market
      • 8.3.2.3 Synthetic Ventral Hernia Repair Market
      • 8.3.2.3.1 Resorbable Synthetic Ventral Hernia Repair Market
      • 8.3.2.3.2 Non-Resorbable Synthetic Ventral Hernia Repair Market
      • 8.3.2.4 Ventral Hernia Repair Market by Care Setting
      • 8.3.2.4.1 Hospital Ventral Hernia Repair Market
      • 8.3.2.4.2 Non-Hospital Ventral Hernia Repair Market
    • 8.3.3 Inguinal Hernia Repair Market
      • 8.3.3.1 Allograft Inguinal Hernia Repair Market
      • 8.3.3.2 Xenograft Inguinal Hernia Repair Market
      • 8.3.3.3 Synthetic Inguinal Hernia Repair Market
      • 8.3.3.4 Inguinal Hernia Repair Market by Care Setting
      • 8.3.3.4.1 Hospital Inguinal Hernia Repair Market
      • 8.3.3.4.2 Non-Hospital Inguinal Hernia Repair Market
    • 8.3.4 Hiatal Hernia Repair Market
      • 8.3.4.1 Allograft Hiatal Hernia Repair Market
      • 8.3.4.2 Xenograft Hiatal Hernia Repair Market
      • 8.3.4.2.1 Reinforced Xenograft Hiatal Hernia Repair Market
      • 8.3.4.2.2 Non-Reinforced Xenograft Hiatal Hernia Repair Market
      • 8.3.4.3 Synthetic Hiatal Hernia Repair Market
      • 8.3.4.3.1 Resorbable Synthetic Hiatal Hernia Repair Market
      • 8.3.4.3.2 Non-Resorbable Synthetic Hiatal Hernia Repair Market
      • 8.3.4.4 Hiatal Hernia Repair Market by Care Setting
      • 8.3.4.4.1 Hospital Hiatal Hernia Repair Market
      • 8.3.4.4.2 Non-Hospital Hiatal Hernia Repair Market
  • 8.4 Drivers and Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Dural repair Market

  • 9.1 Introduction
  • 9.2 Market Overview
    • 9.2.1 Dural Repair Market by Material Type
    • 9.2.2 Dural Repair Market by Care Setting
  • 9.3 Market Analysis and Forecast
    • 9.3.1 Dural Repair Market
    • 9.3.2 Dural Repair Market by Material Type
      • 9.3.2.1 Allograft Dural Repair Market
      • 9.3.2.2 Xenograft Dural Repair Market
      • 9.3.2.3 Synthetic Dural Repair Market
    • 9.3.3 Dural Repair Market by Care Setting
      • 9.3.3.1 Hospital Dural Repair Market
      • 9.3.3.2 Non-Hospital Dural Repair Market
  • 9.4 Drivers and Limiters
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 Competitive Market Share Analysis

Nerve repair Market

  • 10.1 Introduction
  • 10.2 Market Overview
    • 10.2.1 Nerve Repair Market by Product Type
    • 10.2.2 Nerve Repair Market by Care Setting
  • 10.3 Market Analysis and Forecast
    • 10.3.1 Nerve Repair Market
    • 10.3.2 Nerve Repair Market by Product Type
      • 10.3.2.1 Nerve Wrap Market
      • 10.3.2.2 Nerve Graft Market
      • 10.3.2.3 Nerve Tube Market
      • 10.3.2.4 Nerve Cap Market
    • 10.3.3 Nerve Repair Market by Care Setting
      • 10.3.3.1 Hospital Nerve Repair Market
      • 10.3.3.2 Non-Hospital Nerve Repair Market
  • 10.4 Drivers and Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Cardiovascular Patch repair Market

  • 11.1 Introduction
  • 11.2 Market Overview
    • 11.2.1 Cardiovascular Patch Repair Market by Material Type
    • 11.2.2 Cardiovascular Patch Repair Market by Segment
  • 11.3 Market Analysis and Forecast
    • 11.3.1 Cardiovascular Patch Repair Market
    • 11.3.2 Cardiac Patch Market
      • 11.3.2.1 Allograft Cardiac Patch Market
      • 11.3.2.2 Xenograft Cardiac Patch Market
      • 11.3.2.3 Synthetic Cardiac Patch Market
    • 11.3.3 Vascular Patch Market
      • 11.3.3.1 Xenograft Vascular Patch Market
      • 11.3.3.2 Synthetic Vascular Patch Market
  • 11.4 Drivers and Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Soft Tissue Repair Market by Segment, U.S., 2023 - 2030
  • Chart 1-2: Soft Tissue Repair Market Overview, U.S., 2023 & 2030
  • Chart 2-1: Multi-Scenario U.S. Soft Tissue Repair Market Forecast, U.S., 2020 - 2030 (US$M)
  • Chart 5-1: Soft Tissue Repair Market by Segment, U.S., 2020 - 2030
  • Chart 5-2: Leading Competitors, Soft Tissue Repair Market, U.S., 2023
  • Chart 6-1: Soft Tissue Repair Procedures by Segment, U.S., 2020 - 2030
  • Chart 7-1: Breast Reconstruction Market by Material Type, 2020 - 2030 (US$M)
  • Chart 7-2: Breast Reconstruction Market by Procedure Type, U.S., 2020 - 2030 (US$M)
  • Chart 7-3: Breast Reconstruction Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Chart 7-4: Leading Competitors, Breast Reconstruction Market, U.S., 2023
  • Chart 8-1: Hernia Repair Market by Segment, 2020 - 2030 (US$M)
  • Chart 8-2: Hernia Repair Market by Material Type, 2020 - 2030 (US$M)
  • Chart 8-3: Leading Competitors, Hernia Repair Market, U.S., 2023
  • Chart 9-1: Dural Repair Market by Material Type, U.S., 2020 - 2030
  • Chart 9-2: Dural Repair Market by Care Setting, U.S., 2020 - 2030
  • Chart 9-3: Leading Competitors, Dural Repair Market, U.S., 2023
  • Chart 10-1: Nerve Repair Market by Product Type, U.S., 2020 - 2030
  • Chart 10-2: Nerve Repair Market by Care Setting, U.S., 2020 - 2030
  • Chart 10-3: Leading Competitors, Nerve Repair Market, U.S., 2023
  • Chart 11-1: Cardiovascular Patch Repair Market by Material, U.S., 2020 - 2030
  • Chart 11-2: Cardiovascular Patch Repair Market by Segment, U.S., 2020 - 2030
  • Chart 11-3: Leading Competitors, Cardiovascular Patch Repair Market, U.S., 2023

LIST OF FIGURES

  • Figure 1-1: Soft Tissue Repair Market Share Ranking by Segment, U.S., 2023
  • Figure 1-2: Companies Researched in This Report
  • Figure 1-3: Factors Impacting the Soft Tissue Repair Market by Segment, U.S.
  • Figure 1-4: Recent Events in the Soft Tissue Repair Market, U.S., 2021 - 2024
  • Figure 1-5: Soft Tissue Repair Procedures Covered (1 of 2)
  • Figure 1-6: Soft Tissue Repair Procedures Covered (2 of 2)
  • Figure 1-7: Procedure Codes Investigated
  • Figure 1-8: Soft Tissue Repair Markets Covered (1 of 2)
  • Figure 1-9: Soft Tissue Repair Markets Covered (2 of 2)
  • Figure 1-10: Key Report Updates
  • Figure 1-11: Version History
  • Figure 2-1: U.S. Soft Tissue Repair Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M)
  • Figure 2-2: U.S. Soft Tissue Repair Market by Segment, Base Case Scenario, U.S., 2020 - 2030 (US$M)
  • Figure 2-3: U.S. Soft Tissue Repair Market by Segment, Best Case Scenario, U.S., 2020 - 2030 (US$M)
  • Figure 4-1: Breast Reconstruction Products Market by Company
  • Figure 4-2: Hernia Repair Market Products by Company
  • Figure 4-3: Dural Repair Market Products by Company
  • Figure 4-4: Nerve Repair Market by Company
  • Figure 4-5: Cardiovascular Repair Market by Company
  • Figure 4-6: Class 2 Device Recall Ventralight" ST Mesh with Echo PS" Positioning System
  • Figure 4-7: Class 2 Device Recall Parietex
  • Figure 4-8: Class 2 Device Recall Covidien
  • Figure 4-9: Class 2 Device Recall VERITAS Collagen Matrix
  • Figure 4-10: Class 2 Device Recall Proceed Surgical Mesh
  • Figure 4-11: Class 2 Device Recall Gentrix Surgical Matrix Thick
  • Figure 4-12: Class 2 Device Recall Durepair Dura Substitute
  • Figure 4-13: Class 2 Device Recall DuraMatrix Collagen Dura Substitute Membranes
  • Figure 4-14: Class 3 Device Recall NeuraGen Nerve Guide
  • Figure 4-15: Class 2 Device Recall Baxter PeriGuard
  • Figure 4-16: Class 2 Device Recall Baxter VascuGuard
  • Figure 4-17: Class 2 Device Recall Baxter Floseal
  • Figure 4-18: Class 2 Device Recall VASCUTEK/TERUMO
  • Figure 4-19: Class 2 Device Recall CryoPatch SG Pulmonary Human Cardiac Patch
  • Figure 4-20: BREAST ADM Trial for Alloplastic Breast Reconstruction
  • Figure 4-21: Histological Analysis of AlloMend(R) Acellular Dermal Matrix Used in Breast Implant Surgeries
  • Figure 4-22: Comparing AlloDerm and DermACELL in Breast Reconstruction
  • Figure 4-23: Evaluation of ADM Soft Tissue Reinforcement
  • Figure 4-24: Ventral or Inguinal Hernia, Robotically Repaired with OviTex Mesh
  • Figure 4-25: A Comparison of the Outcomes in Fortiva and Strattice Mesh
  • Figure 4-26: Biosynthetic Absorbable Mesh vs Standard of Repair for the Surgical Treatment of Infected Incisional Hernia (COMpACT-BIO)
  • Figure 4-27: A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair
  • Figure 4-28: A Prospective Case Series Evaluating Surgimend Mp(R) In Patients Undergoing Complex Abdominal Hernia Repair
  • Figure 4-29: Mesh Type in Ventral Hernia Repair
  • Figure 4-30: Post Market Study of Parietene(TM) DS Composite Mesh in Ventral Hernia Repair (PPDS)
  • Figure 4-31: Clinical Study on the Safety of SAFIL(R) MESH
  • Figure 4-32: Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias (ventral hernia)
  • Figure 4-33: Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant(R)
  • Figure 4-34: A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia(R) Dural Repair Patch Compared with Commercially Available Dural Substitutes.
  • Figure 4-35: NeuraGen 3D Pilot Study

Figure 4-36 TISSIUM(TM) Nerve Coaptation Device First-in-Human Clinical Trial:

Figure 4-37 Study of AxoGuard(R) Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

Figure 4-38 PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

  • Figure 4-39: Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON)
  • Figure 4-40: Registry of Avance(R) Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction (RANGER(R))
  • Figure 5-1: Soft Tissue Repair Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 5-2: Leading Competitors, Soft Tissue Repair Market, U.S., 2023
  • Figure 5-3: SWOT Analysis, AbbVie
  • Figure 5-4: SWOT Analysis, Artivion
  • Figure 5-5: SWOT Analysis, Axogen
  • Figure 5-6: SWOT Analysis, Becton Dickinson
  • Figure 5-7: SWOT Analysis, Integra LifeSciences
  • Figure 5-8: SWOT Analysis, Medtronic
  • Figure 5-9: SWOT Analysis, MTF Biologics
  • Figure 5-10: SWOT Analysis, Stryker
  • Figure 5-11: SWOT Analysis, W.L. Gore
  • Figure 6-1: Procedure Codes Investigated, U.S., 2023
  • Figure 6-2: Soft Tissue Repair Procedures by Segment, U.S., 2020 - 2030
  • Figure 6-3: Breast Reconstruction Procedures by Method, U.S., 2020 - 2030
  • Figure 6-4: Implant-Based Breast Reconstruction Procedures by Method, U.S., 2020 - 2030
  • Figure 6-5: Implant-Based Breast Reconstruction Procedures by Timing, U.S., 2020 - 2030
  • Figure 6-6: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2020 - 2030
  • Figure 6-7: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2020 - 2030
  • Figure 6-8: Implant-Based Breast Reconstruction Procedures by Devices Used, U.S., 2020 - 2030
  • Figure 6-9: Autologous Breast Reconstruction Procedures by Timing, U.S., 2020 - 2030
  • Figure 6-10: Autologous Breast Reconstruction Procedures by Type, U.S., 2020 - 2030
  • Figure 6-11: Breast Reconstruction Procedures by Care Setting, U.S., 2020 - 2030
  • Figure 6-12: Hernia Repair Procedures by Type, U.S., 2020 - 2030
  • Figure 6-13: Hernia Repair Procedures by Care Setting, U.S., 2020 - 2030
  • Figure 6-14: Hernia Repair Procedures by Robotic Assistance, U.S., 2020 - 2030
  • Figure 6-15: Dural Repair Procedures by Care Setting, U.S., 2020 - 2030
  • Figure 6-16: Cardiovascular Patch Repair Procedures, U.S., 2020 - 2030
  • Figure 6-17: Nerve Repair Procedures by Care Setting, U.S., 2020 - 2030
  • Figure 7-1: Breast Reconstruction Market by Material Type, U.S., 2020 - 2030 (US$M)
  • Figure 7-2: Breast Reconstruction Market by Procedure Type, U.S., 2020 - 2030 (US$M)
  • Figure 7-3: Breast Reconstruction Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 7-4: Breast Reconstruction Market, U.S., 2020 - 2030
  • Figure 7-5: Allograft Breast Reconstruction Market, U.S., 2020 - 2030
  • Figure 7-6: Xenograft Breast Reconstruction Market, U.S., 2020 - 2030
  • Figure 7-7: Synthetic Breast Reconstruction Market, U.S., 2020 - 2030
  • Figure 7-8: Leading Competitors, Breast Reconstruction Market, U.S., 2023
  • Figure 8-1: Hernia Repair Market by Material Type, U.S., 2020 - 2030 (US$M)
  • Figure 8-2: Hernia Repair Market by Material Type, U.S., 2020 - 2030 (US$M)
  • Figure 8-3: Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-4: Allograft Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-5: Xenograft Ventral Hernia Repair Market by Segment, U.S., 2020 - 2030
  • Figure 8-6: Xenograft Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-7: Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-8: Non-Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-9: Synthetic Ventral Hernia Repair Market by Segment, U.S., 2020 - 2030
  • Figure 8-10: Synthetic Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-11: Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-12: Non-Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-13: Ventral Hernia Repair Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 8-14: Hospital Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-15: Non-Hospital Ventral Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-16: Allograft Inguinal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-17: Xenograft Inguinal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-18: Synthetic Inguinal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-19: Inguinal Hernia Repair Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 8-20: Hospital Inguinal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-21: Non-Hospital Inguinal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-22: Allograft Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-23: Xenograft Hiatal Hernia Repair Market by Segment, U.S., 2020 - 2030
  • Figure 8-24: Xenograft Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-25: Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-26: Non-Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-27: Synthetic Hiatal Hernia Repair Market by Segment, U.S., 2020 - 2030
  • Figure 8-28: Synthetic Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-29: Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-30: Non-Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-31: Hiatal Hernia Repair Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 8-32: Hospital Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-33: Non-Hospital Hiatal Hernia Repair Market, U.S., 2020 - 2030
  • Figure 8-34: Leading Competitors, Hernia Repair Market, U.S., 2023
  • Figure 9-1: Dural Repair Market by Material Type, U.S., 2020 - 2030 (US$M)
  • Figure 9-2: Dural Repair Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 9-3: Dural Repair Market, U.S., 2020 - 2030
  • Figure 8-4: Allograft Dural Repair Market, U.S., 2020 - 2030
  • Figure 9-5: Xenograft Dural Repair Market, U.S., 2020 - 2030
  • Figure 9-6: Synthetic Dural Repair Market, U.S., 2020 - 2030
  • Figure 9-7: Hospital Dural Repair Market, U.S., 2020 - 2030
  • Figure 9-8: Non-Hospital Dural Repair Market, U.S., 2020 - 2030
  • Figure 9-9: Leading Competitors, Dural Repair Market, U.S., 2023
  • Figure 10-1: Nerve Repair Market by Product Type, U.S., 2020 - 2030 (US$M)
  • Figure 10-2: Nerve Repair Market by Care Setting, U.S., 2020 - 2030 (US$M)
  • Figure 10-3: Nerve Repair Market, U.S., 2020 - 2030
  • Figure 10-4: Nerve Wrap Market, U.S., 2020 - 2030
  • Figure 10-5: Nerve Graft Market, U.S., 2020 - 2030
  • Figure 10-6: Nerve Tube Market, U.S., 2020 - 2030
  • Figure 10-7: Nerve Cap Market, U.S., 2020 - 2030
  • Figure 10-8: Hospital Nerve Repair Market, U.S., 2020 - 2030
  • Figure 10-9: Non-Hospital Nerve Repair Market, U.S., 2020 - 2030
  • Figure 10-10: Leading Competitors, Nerve Repair Market, U.S., 2023
  • Figure 11-1: Cardiovascular Patch Repair Market by Material, U.S., 2020 - 2030 (US$M)
  • Figure 11-2: Cardiovascular Patch Repair Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-3: Cardiovascular Patch Repair Market, U.S., 2020 - 2030
  • Figure 11-4: Cardiac Patch Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-5: Cardiac Patch Market, U.S., 2020 - 2030
  • Figure 11-6: Allograft Cardiac Patch Market, U.S., 2020 - 2030
  • Figure 11-7: Xenograft Cardiac Patch Market, U.S., 2020 - 2030
  • Figure 11-8: Synthetic Cardiac Patch Market, U.S., 2020 - 2030
  • Figure 11-9: Vascular Patch Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 11-10: Vascular Patch Market, U.S., 2020 - 2030
  • Figure 11-11: Xenograft Vascular Patch Market, U.S., 2020 - 2030
  • Figure 11-12: Synthetic Vascular Patch Market, U.S., 2020 - 2030
  • Figure 11-13: Leading Competitors, Cardiovascular Patch Repair Market, U.S., 2023